SBIO ETF
ALPS Medical Breakthroughs ETF
SBIO ETF Overview
SBIO ETF (ALPS Medical Breakthroughs ETF) is managed by ALPS Advisors with $179.2M in net assets. SBIO expense ratio is 0.50%, holding 105 positions across sectors including Health Care. Inception date: 2014-12-30.
SBIO performance shows a YTD return of 16.07%. The 1-year return is 50.30% and the 5-year return is 8.07%.
SBIO top holdings include Cg Oncology Inc (3.7%), Oruka Therapeutics Inc Orka (3.5%), Travere Therapeutics Inc (3.4%), Dianthus Therapeutics Inc (3.2%), Definium Therapeutics, Inc. Common Shares (3.2%). Go to all SBIO holdings, SBIO sectors, or SBIO dividends.
SBIO can be compared against other funds. Use SBIO overlap to find shared positions, or SBIO vs another fund for a side-by-side view. SBIO alternatives are available via the screener, along with tax-loss harvesting opportunities.